| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/22/2013 | CN103113377A Process for extracting active chlorophyll from green vegetable leaves |
| 05/22/2013 | CN103113376A Alkaloid, and preparation method and application thereof |
| 05/22/2013 | CN103113375A Pyrazolo [3, 4-d] pyrimidine compounds and preparation method thereof |
| 05/22/2013 | CN103111328A Magnetic ionic metal porphyrin catalyst and preparation method thereof |
| 05/22/2013 | CN101506211B 激酶拮抗剂 Kinase antagonists |
| 05/22/2013 | CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents |
| 05/21/2013 | US8445698 Process for the preparation of an intermediate of tadalafil |
| 05/21/2013 | US8445676 Pyrrolotriazine kinase inhibitors |
| 05/21/2013 | US8445501 Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/21/2013 | CA2560162C Inhibitors of iap |
| 05/16/2013 | WO2013071217A1 Dihydropteridinones |
| 05/16/2013 | WO2013071027A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis |
| 05/16/2013 | WO2013070976A1 Treatment regimens using multiple pharmaceutical agents |
| 05/16/2013 | WO2013069721A1 Metal complex, and adsorbent, absorbent and separator formed of same |
| 05/16/2013 | WO2013068376A1 4h-imidazo[1,2-a]imidazoles for electronic applications |
| 05/16/2013 | WO2013068306A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/16/2013 | WO2013067597A1 Immunomodulatory conjugates |
| 05/16/2013 | US20130123509 Process for the preparation of dimiracetam |
| 05/16/2013 | US20130123501 Process for the preparation of the compound osi-906 |
| 05/16/2013 | US20130123499 Method for Purifying a Fused Pyrrolocarbazole Derivative |
| 05/16/2013 | US20130123284 Heterocyclic compounds useful for kinase inhibition |
| 05/16/2013 | US20130123278 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 05/16/2013 | US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 05/16/2013 | US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 05/16/2013 | US20130123239 Compounds having trpv1 antagonistic activity and uses thereof |
| 05/16/2013 | US20130123236 Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/16/2013 | US20130123230 2-Thiopyrimidinones |
| 05/16/2013 | CA2855372A1 Acc inhibitors and uses thereof |
| 05/16/2013 | CA2854926A1 Treatment regimens using multiple pharmaceutical agents |
| 05/16/2013 | CA2850458A1 [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 |
| 05/15/2013 | EP2592130A1 Photochromic material |
| 05/15/2013 | EP2592083A1 Fused quinazoline derivatives and uses thereof |
| 05/15/2013 | EP2591056A1 Metallation enhancements in tumor-imaging and pdt therapy |
| 05/15/2013 | EP2590983A2 Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectric applications |
| 05/15/2013 | EP2590982A1 Protein kinase inhibitors and methods of treatment |
| 05/15/2013 | EP2590981A1 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 05/15/2013 | EP2590980A1 Fused heterocyclic derivatives as s1p modulators |
| 05/15/2013 | EP2590979A1 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
| 05/15/2013 | EP2590978A2 Carbapenem antibacterials with gram-negative activity |
| 05/15/2013 | EP2590953A1 Tetrazole compounds as calcium channel blockers |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | EP2590657A1 Organic compounds |
| 05/15/2013 | CN1863891B Organic compound and organic light emitting device using the same |
| 05/15/2013 | CN103108876A 2 -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 05/15/2013 | CN103108875A Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device |
| 05/15/2013 | CN103108874A Processes for the preparation of dipyridamole |
| 05/15/2013 | CN103102353A Free porphyrin, and preparation method and application thereof |
| 05/15/2013 | CN103102352A Tyrosine kinase inhibitor indolinone derivative |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof |
| 05/15/2013 | CN103102344A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN103100080A Application of cGP and derivatives in preparation of medicine for inhibiting tumor growth and regeneration |
| 05/14/2013 | US8440689 Fused heteroaromatic pyrrolidinones |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 05/14/2013 | CA2557433C Quinazoline derivatives and therapeutic use thereof |
| 05/10/2013 | WO2013067274A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067260A1 Bicyclic piperazine compounds |
| 05/10/2013 | WO2013065712A1 Diazaspirourea derivative and pharmaceutical use thereof |
| 05/10/2013 | WO2013065066A1 Processes for preparing 4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro [l,2,41-triazolo[43-a]pyrazin-7(8h)-yl]-l-(2,4,5- trifluorophenyl)butan-2-amine |
| 05/10/2013 | WO2013064984A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/10/2013 | WO2013064467A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase |
| 05/10/2013 | WO2013064445A1 Imidazopyridazine compounds |
| 05/10/2013 | WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3) |
| 05/10/2013 | WO2013064153A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| 05/10/2013 | WO2013064083A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof |
| 05/10/2013 | WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
| 05/10/2013 | WO2012112548A3 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis |
| 05/10/2013 | CA2855019A1 Biaryl ether sulfonamides and their use as therapeutic agents |
| 05/10/2013 | CA2853975A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity |
| 05/10/2013 | CA2852964A1 Bicyclic piperazine compounds |
| 05/10/2013 | CA2849194A1 Imidazopyridazine compounds |
| 05/10/2013 | CA2848824A1 Azetidine compounds, compositions and their use as inhibitors of soluble epoxide hydrolase |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/09/2013 | US20130116266 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 05/09/2013 | US20130116265 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 05/09/2013 | US20130116262 Bicyclic piperazine compounds |
| 05/09/2013 | US20130116260 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 05/09/2013 | US20130116258 Androgen receptor modulators and uses thereof |
| 05/09/2013 | US20130116246 8-fluorophthalazin-1(2h)-one compounds |
| 05/09/2013 | US20130116245 Alkylated piperazine compounds |
| 05/09/2013 | US20130116236 Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives |
| 05/09/2013 | US20130116235 Heteroaryl pyridone and aza-pyridone compounds |
| 05/09/2013 | US20130116232 Estrogen receptor modulators and uses thereof |
| 05/09/2013 | US20130115699 Polyplex gene delivery vectors |
| 05/09/2013 | US20130115193 Hepatitis C Virus Inhibitors |
| 05/09/2013 | US20130112952 Depositing premixed materials |
| 05/08/2013 | EP2589601A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 05/08/2013 | EP2588480A2 3,4-DIHYDROPYRROLO[1,2-A]PYRAZINE-2,8(1H)-DICARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF& xA; |
| 05/08/2013 | EP2588478A1 Azaindole derivative |
| 05/08/2013 | EP2588469A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 05/08/2013 | EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/08/2013 | CN103098253A Organic electroluminescent element |
| 05/08/2013 | CN103097393A Quinoxaline compound |
| 05/08/2013 | CN103097390A Application of beta-functionalized dihydroxy-chlorins for PDT |